|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||8.16 / 29.41|
This is one of those days when it may pay to walk away.
New Patents Cover Method of Use and Method of Manufacturing
Home builders make up the second-largest allocation in my portfolio, behind biotech.
Stocks fall on Thursday afternoon after House leaders delay a highly anticipated vote on the Republicans' repeal-and-replace health care bill.
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Flexion Therapeutics, Inc. , where a total volume of 1,667 contracts has been traded thus far today, a contract volume which is representative of approximately 166,700 underlying shares (given that every 1 contract represents 100 underlying shares).
At stake is whether the Republicans can work out their differences.
The most recent short interest data has been released for the 11/30/2016 settlement date, which shows a 254,831 share decrease in total short interest for Flexion Therapeutics, Inc. , to 1,028,455, a decrease of 19.86% since 11/15/2016.
Investors considering a purchase of Flexion Therapeutics, Inc. shares, but tentative about paying the going market price of $17.89/share, might benefit from considering selling puts among the alternative strategies at their disposal.
Podium Presentation at the AAHKS Annual Meeting Shows Zilretta Delivers Extended Relief Compared to Immediate-Release Steroid and Placebo
In trading on Thursday, shares of Flexion Therapeutics, Inc. touched a new 52-week high of $22.00/share.